STA
BIVV

Summit Trail Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Summit Trail Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,460
Closed -$114K – 2105
2017
Q4 		$114K Buy
+1,460
New +$79.9K 0.01% 589

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Summit Trail Advisors's BIVV Position: Q1 2018 in Review

Summit Trail Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,460 shares — an estimated $114K sold.

Summit Trail Advisors first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $114K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Summit Trail Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 1,460 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $114K.
  • Summit Trail Advisors first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Bioverativ Inc. Common Stock position peaked at $114K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.